Guggenheim Aviation Partners (GAP) today announced the delivery of a Boeing 777-300ER to Korean Air, marking the successful completion of the first leasing arrangement between the two firms. GAP is a leading participant in commercial aircraft leasing with offices in Seattle, London and Singapore. Korean Air, a premier global airline, is headquartered in Seoul. “We are pleased and honored to have Korean Air as our customer,” said Steve Rimmer, GAP’s Chief Executive. “Their commitment to excellence is aligned with our business philosophy as well, and we look forward to serving them in the years ahead.” S.K. Lee, Korean Air’s Managing Vice President of Procurement, commented, “We are pleased to be able to add this 777-300ER to our fleet in such a timely manner, and appreciate Guggenheim’s ability to provide a smooth and professional transaction.” For GAP, the transaction commemorates not only the firm’s first transaction with Korean Air, but also its first purchase of a 777-300ER and the first new-production passenger aircraft acquired from Boeing.
About Guggenheim Partners Guggenheim Partners, LLC is a diversified financial services firm with more than $100 billion in assets under supervision. The firm’s businesses include investment management, investment advisory, insurance, investment banking and capital markets services. The firm is headquartered in Chicago and New York with a global network of offices throughout the United States, Europe and Asia.
NEW YORK, NY – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that David Levin will join the firm as a Senior Managing Director in Equity Capital Markets, focusing on providing clients with equity and equity-linked financing solutions through the public and alternative equity capital markets.
Read More
NEW YORK, NY – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Joe Niemiec has joined the firm as a Senior Managing Director to expand its middle market investment banking coverage and to focus on advising companies in the services and industrials sectors.
NEW YORK, NY – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Debjit Chattopadhyay will join the firm in December as a Managing Director and Senior Biotech Analyst as part of the Healthcare Equity Research team. Dr. Chattopadhyay’s research focus will be gene therapy and rare diseases.
You are now leaving this website.Guggenheim assumes no responsibility of the content or its accuracy.
© 2020 Guggenheim Partners, LLC. All rights reserved. Guggenheim, Guggenheim Partners and Innovative Solutions. Enduring Values. are registered trademarks of Guggenheim Capital, LLC.
We use cookies on our site. You may control whether and how your browser accepts cookies; please see your browser help documentation for more information. To learn more about the information we collect and how we use it, view our Privacy Policy.